drugset / Trial / NCT03661996

An Open-label, 8-week Safety, Efficacy, and Assessment of Cooling Methods for Administration of CNTX-4975-05 for Knee OA

NCT03661996

Phase 3 Completed 854 enrolled Centrexion Therapeutics
RandomizedParallel-groupOpen-labelTreatment

Summary

An Open-label, 8-Week Study to Compare the Comfort and Ease of Use of Five Different Treatment Regimens for CNTX 4975-05 Intra-articular Injection in Subjects with Chronic, Moderate-to-Severe Osteoarthritis Knee Pain.

Timeline

Start
2018-09-18
Primary completion
2019-10-22
Completion
2019-10-22

Drugs

EvaluationDrugModalityDoseRoute
Subject CNTX-4975-05 Unknown Other
Background Lidocaine Other / unclassified 15 ml Other

Indications